Daniela Noain

Daniela Noain currently serves as a Principal Investigator at the University Hospital of Zurich, where she leads the Animal Sleep Laboratory within the Neurology Department. In this pivotal role, she oversees cutting-edge research focused on the intricate relationship between sleep physiology and neurodegeneration. Her expertise in neurobiology, combined with her extensive skills in in vivo electrophysiology, behavioral neuroscience, and molecular pharmacology, positions her at the forefront of translational sleep research. Daniela’s team investigates how alterations in brain slow waves during sleep influence neuroplasticity and the progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

A key aspect of her work involves developing novel experimental paradigms to explore sleep’s therapeutic potential, aiming to implement sleep-based interventions for brain health and disease prevention. She actively supervises master’s and PhD students, fostering a collaborative environment that emphasizes experimentation, data analysis, and the integration of molecular and electrophysiological techniques. Her research not only advances our understanding of sleep’s role in neurodegeneration but also contributes to the development of innovative strategies for managing sleep disorders and promoting brain resilience.

In addition to her research activities, Daniela collaborates with neurology residents on translational projects, bridging the gap between basic science and clinical application. Her dedication to advancing sleep research underscores her commitment to improving neurological health through a deeper understanding of sleep’s fundamental role in neuroplasticity and neurodegeneration, positioning her as a key figure in the evolving landscape of neurobiology and sleep medicine.